QualityStocksNewsBreaks Archives - Page 633 of 1622

TuesdayMay 10, 2022 10:50 am

QualityStocksNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Announces Webinar to Showcase Lidar Applications in Smart Infrastructure

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance MMT(R) lidar solutions, together with Lidar News will host a free webinar at 10:30 a.m. PT/1:30 p.m. ET on Tuesday, May 24, 2022. The webinar will focus on the use of lidar to enable higher levels of accuracy and efficiency of smart infrastructure applications, with examples of real-world deployments. Interested parties should visit https://ibn.fm/TAK3M to register for the event. “As Cepton CEO Dr. Jun Pei always says, people’s desire for safety will never end,” said Cepton’s Director of Product Management and Marketing, Klaus Wagner. “Lidar not only enables high-precision…

TuesdayMay 10, 2022 10:39 am

QualityStocksNewsBreaks – Eat Well Investment Group Inc.’s (CSE: EWG) (OTC: EWGFF) Releases Statement on Filing FY 2021 Financials, Other Required Documents

Eat Well Group (CSE: EWG) (OTC: EWGFF), a publicly traded investment company, has announced plans for filing its audited annual financial statements for the year ended Nov. 30, 2021; the company anticipates completing and filing the required documents by May 30, 2022. Eat Well also noted other documents, such as certificates of its CEO and CFO, that are related to the previously announced management cease trade order (“MCTO”) issued to Eat Well by the British Columbia Securities Commission. The company is working diligently to meet the guidelines in order to return to full trading status; those efforts include providing biweekly…

MondayMay 09, 2022 2:13 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Leveraging Advantage in Rare Cannabinoid Biosynthesis Space

InMed Pharmaceuticals (NASDAQ: INM) is a clinical-stage company currently developing a pipeline of cannabinoid-based pharmaceutical drug candidates to treat several diseases with high, unmet medical needs. The company’s focus is on rare cannabinoids, many of which are not yet available in commercial-size quantities, such as cannabidivarin – (“CBDV”) and tetrahydrocannabivarin – (“THCV”). “The acquisition of BayMedica in October 2021 has provided an advantage for InMed in the rare cannabinoid biosynthesis industry,” reads a recent article discussing the company. “BayMedica is a private U.S. firm specializing in the manufacturing and commercialization of rare cannabinoids for the health and wellness sector and…

MondayMay 09, 2022 12:42 pm

QualityStocksNewsBreaks – GreenBox POS (NASDAQ: GBOX) Plans to Report Q1 2022 Results on May 16

GreenBox (NASDAQ: GBOX), an emerging and rapidly growing fintech company, has announced its intention to release its first quarter 2022 financial results after market close on Monday, May 16, 2022. As part of that release strategy, company executives will host a conference call/webcast to discuss the results and provide a corporate update on that same day; the call will include a Q&A session. The call is slated to start at 4:30 p.m. ET, and those who are interested can dial 1-844-825-9789 in the United States or 1-412-317-5180 internationally, using the conference ID 10166964; callers are encouraged to dial in at least 10…

FridayMay 06, 2022 3:45 pm

QualityStocksNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Committed to Bridge Divide Between Cutting-Edge Science and Automotive Industry

Cepton (NASDAQ: CPTN) recently became a sponsor and an exclusive LiDAR provider for ten universities in North America gathered in a four-year STEM education program called The AutoDrive Challenge(TM) II. The program is designed to advance STEM education and contribute to groundbreaking work within the autonomous driving space. “As a leading innovator in the LiDAR space, Cepton has always been committed to becoming the bridge between cutting-edge science and the automotive industry. Autonomous driving and its great enabler – LiDAR technology – are ready to take over the mobility space as the innovative technology makes strides in terms of decreasing…

FridayMay 06, 2022 3:10 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH-Nicotine Pouch Performance to Be Compared to That of Leading Brands

Lexaria Bioscience Corp. (NASDAQ: LEXX) is expected to begin dosing for the NIC-H22-1 human study this summer. “NIC-H22-1, a pharmacokinetic randomized, double-blinded, cross-over study involving 36 human participants, will compare Lexaria’s DehydraTECH-nicotine pouch performance to that of existing leading brands available to U.S. customers, namely ON! and Zyn,” a recent article reads. The human study NIC-H22-1 is expected to build on the successes of the company’s animal studies, which have proven the technology’s effectiveness in promoting faster absorption, higher peak absorption, and greater overall quantities of nicotine, on average, in the blood than concentration-matched control formulations. “In 2021, the company…

FridayMay 06, 2022 2:58 pm

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Building on Growth Momentum to Bring Cutting-Edge Solutions

SRAX (NASDAQ: SRAX) is a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform. The company appears poised to build upon its growth momentum to expand beyond the investor relations space to include integrated cross-organizational solutions that can be deployed across multiple departments. A recent article reads: “The company continues to go from strength to strength and has grand plans for 2022. In a recent episode of a Sequire Spotlight series called Sequire Spotlight Presents SRAX (SRAX): The Savvy Solution to Investor Relations, SRAX’s CEO Christopher Miglino revealed that the product…

FridayMay 06, 2022 2:55 pm

QualityStocksNewsBreaks – Hero Technologies Inc. (HENC) Positioning in 3 of Top 6 US Cannabis Markets

Hero Technologies (OTC: HENC), a cannabis company, is ideally poised as a new report revealed that states that have legalized recreational marijuana collected an estimated $3.7 billion in tax revenue last year. “That news bodes well for savvy players in the legal cannabis space, including Hero Technologies, as states are often eager to support revenue sources,” a recent article reads. “Hero Technologies is looking to leverage its cannabis expertise in more of those states. The company currently has a majority stake in BlackBox Systems and Technologies LLC, which has been operating legally in Michigan as a medical caregiver. HENC is…

FridayMay 06, 2022 2:28 pm

QualityStocksNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Executing Aggressive Growth Strategy

EverGen (TSX.V: EVGN) (OTCQB: EVGIF) is focused on combatting climate change and contributing to a sustainable future as an independent renewable energy producer that acquires, develops, builds, owns, and operates a portfolio of renewable natural gas (“RNG”), waste-to-energy, and related infrastructure projects. “Using RNG solves multiple problems our world faces today, namely reducing emissions and responsibly disposing of waste that otherwise would pollute the atmosphere…. Compared to fossil fuels, renewable compressed natural gas can slash carbon dioxide emissions by 50%,” a recent article reads. “Fact is that while electric vehicles may get all the headlines, RNG is quietly gathering plenty…

FridayMay 06, 2022 2:14 pm

QualityStocksNewsBreaks – Silo Pharma Inc. (SILO), Frontage Laboratories to Collaborate in Pharmacokinetic Study

Silo Pharma (OTCQB: SILO) recently announced an agreement with Frontage Laboratories, a contract research organization, for an Investigational New Drug (“IND”)-enabling pharmacokinetic study. “Silo merges traditional therapeutics with psychedelic research to relieve patients suffering from PTSD, Alzheimer’s, Parkinson’s, and other rare neurological disorders,” a recent article reads. “Frontage will study Silo’s central nervous system peptide, SPU-16, ’a potential new treatment for multiple sclerosis and other conditions,’ and the company’s joint homing peptide, SPU-21, used for treating arthritogenic processes, which, according to Silo Pharma CEO Eric Weisblum, could, ‘enhance the therapeutic effect of current and future therapeutics while decreasing potential systemic…

Site Search

Company Search

Category: QualityStocksNewsBreaks